In particular, the NBP2/nbp2 heterozygote is multiply drug-hypertolerant, of note since its ortholog SH3GL1 frequently has reduced copy-number in serous cystadenocarcinoma. Here, SH3GL1 is linked to serous cystadenocarcinoma.